tiprankstipranks
Evogene Back in Compliance with Nasdaq Rule
Company Announcements

Evogene Back in Compliance with Nasdaq Rule

Evogene (EVGN) has released an update.

Don't Miss our Black Friday Offers:

Evogene Ltd., a computational biology company, has successfully regained compliance with Nasdaq’s Listing Rule by maintaining a minimum bid price of $1.00 per share over 10 consecutive business days. The company specializes in life-science product discovery using AI and big data, with a focus on developing therapeutics, ag-biologicals, crop protection chemicals, and high-grade industrial biofuels through its subsidiaries.

For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyEvogene price target lowered to $5 from $12 at Lake Street
TipRanks Auto-Generated NewsdeskEvogene Sees Revenue Growth and Expands AI Collaboration
TheFlyEvogene reports Q3 EPS ($1.31) vs. (81c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App